Charlotte Joly
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Charlotte Joly has a total of 50 co-authors. Here are the top co-authors by number of shared publications:
- Estelle Pujos-Guillot
Université Clermont Auvergne, INRAE, UNH, Plateforme d’Exploration du Métabolisme, MetaboHUB Clermont, Clermont-Ferrand, France
8 shared publications - Stéphanie Durand
Université Clermont Auvergne, INRAE, UNH, Plateforme d’Exploration du Métabolisme, MetaboHUB Clermont, Clermont-Ferrand, France
7 shared publications - Angélique Abila
Université Clermont Auvergne, INRAE, UNH, Plateforme d’Exploration du Métabolisme, MetaboHUB Clermont, Clermont-Ferrand, France. 3
5 shared publications - Anne-Laure Martin
UNICANCER, Paris, France
5 shared publications - Aurélie Bertaut
Biostatistics, Centre Georges-François Leclerc (CGFL), Dijon, France
5 shared publications - Baptiste Sauterey
Department of Medical Oncology, Institut de Cancérologie de L’ouest , Angers
5 shared publications
Latest Publications
- Open Access
- 22 September 2025
- Published by Springer Nature
Fecal or caecal waters sample preparation for untargeted GCMS-based metabolomic v1
The following protocol describes the preparation of fecal or caecal water samples for non-targeted analysis by mass spectrometry coupled to gas chromatography as proposed by the PFEM (MetaboHUB-Clermont). The steps cover the sample preparation and quality control. The expected outcome of this protocol is a list of fecal or caecal water samples ready for analysis by GCMS.
- 22 September 2025
- Published by Springer Nature
Open AccessFecal or caecal waters sample preparation for untargeted GCMS-based metabolomic v1
The following protocol describes the preparation of fecal or caecal water samples for non-targeted analysis by mass spectrometry coupled to gas chromatography as proposed by the PFEM (MetaboHUB-Clermont). The steps cover the sample preparation and quality control. The expected outcome of this protocol is a list of fecal or caecal water samples ready for analysis by GCMS.
- Open Access
- 15 October 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Data 1 from Metabolomic Prediction of Breast Cancer Treatment–Induced Neurologic and Metabolic Toxicities
Supplementary Data 1 from Metabolomic Prediction of Breast Cancer Treatment–Induced Neurologic and Metabolic Toxicities
- 15 October 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Data 1 from Metabolomic Prediction of Breast Cancer Treatment–Induced Neurologic and Metabolic Toxicities
Supplementary Data 1 from Metabolomic Prediction of Breast Cancer Treatment–Induced Neurologic and Metabolic Toxicities
- Open Access
- 15 October 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Data and methods 4 from Metabolomic Prediction of Breast Cancer Treatment–Induced Neurologic and Metabolic Toxicities
Supplementary Data and methods
- 15 October 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Data and methods 4 from Metabolomic Prediction of Breast Cancer Treatment–Induced Neurologic and Metabolic Toxicities
Supplementary Data and methods
- 6 August 2024
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 30 (20) , 4654-4666
Metabolomic Prediction of Breast Cancer Treatment–Induced Neurologic and Metabolic Toxicities
Purpose: Long-term treatment-related toxicities, such as neurologic and metabolic toxicities, are major issues in breast cancer. We investigated the interest of metabolomic profiling to predict toxicities. Experimental Design: Untargeted high-resolution metabolomic profiles of 992 patients with estrogen receptor (ER)+/HER2− breast cancer from the prospective CANTO cohort were acquired (n = 1935 metabolites). A residual-based modeling strategy with discovery and validation cohorts was used to benchmark machine learning algorithms, taking into account confounding variables. Results: Adaptive Least Absolute Shrinkage and Selection (adaptive LASSO) has a good predictive performance, has limited optimism bias, and allows the selection of metabolites of interest for future translational research. The addition of low-frequency metabolites and nonannotated metabolites increases the predictive power. Metabolomics adds extra performance to clinical variables to predict various neurologic and metabolic toxicity profiles. Conclusions: Untargeted high-resolution metabolomics allows better toxicity prediction by considering environmental exposure, metabolites linked to microbiota, and low-frequency metabolites.
- 6 August 2024
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 30 (20) , 4654-4666
Metabolomic Prediction of Breast Cancer Treatment–Induced Neurologic and Metabolic Toxicities
Purpose: Long-term treatment-related toxicities, such as neurologic and metabolic toxicities, are major issues in breast cancer. We investigated the interest of metabolomic profiling to predict toxicities. Experimental Design: Untargeted high-resolution metabolomic profiles of 992 patients with estrogen receptor (ER)+/HER2− breast cancer from the prospective CANTO cohort were acquired (n = 1935 metabolites). A residual-based modeling strategy with discovery and validation cohorts was used to benchmark machine learning algorithms, taking into account confounding variables. Results: Adaptive Least Absolute Shrinkage and Selection (adaptive LASSO) has a good predictive performance, has limited optimism bias, and allows the selection of metabolites of interest for future translational research. The addition of low-frequency metabolites and nonannotated metabolites increases the predictive power. Metabolomics adds extra performance to clinical variables to predict various neurologic and metabolic toxicity profiles. Conclusions: Untargeted high-resolution metabolomics allows better toxicity prediction by considering environmental exposure, metabolites linked to microbiota, and low-frequency metabolites.
- Open Access
- 29 March 2024
- Published by Springer Nature
Urine sample preparation for untargeted MS-based metabolomic v1
The following protocol describes the preparation of urine samples for non-targeted analysis by mass spectrometry coupled to liquid chromatography as proposed by the PFEM (MetaboHUB-Clermont). A pre-analytical normalisation step is carried out based on the osmolality measurement determined for each sample. The steps cover the sample preparation and quality control. The expected outcome of this protocol is a list of urine samples ready for analysis by LCMS.
- 29 March 2024
- Published by Springer Nature
Open AccessUrine sample preparation for untargeted MS-based metabolomic v1
The following protocol describes the preparation of urine samples for non-targeted analysis by mass spectrometry coupled to liquid chromatography as proposed by the PFEM (MetaboHUB-Clermont). A pre-analytical normalisation step is carried out based on the osmolality measurement determined for each sample. The steps cover the sample preparation and quality control. The expected outcome of this protocol is a list of urine samples ready for analysis by LCMS.
- 27 March 2023
- Published by Elsevier in Revue Neurologique
- Vol. 179, S86
Le test d’identification des émotions faciales du 93 (TIE-93) : un outil d’évaluation neuropsychologique adapté aux situations multiculturelles ?
- 27 March 2023
- Published by Elsevier in Revue Neurologique
- Vol. 179, S86
Le test d’identification des émotions faciales du 93 (TIE-93) : un outil d’évaluation neuropsychologique adapté aux situations multiculturelles ?
- Open Access
- 17 December 2020
- Published by MDPI AG in Antioxidants
- Vol. 9 (12) , 1293
Heme-Iron-Induced Production of 4-Hydroxynonenal in Intestinal Lumen May Have Extra-Intestinal Consequences through Protein-Adduct Formation
Some epidemiological studies show that heme iron consumption, in red meat, is associated to the development of several chronic diseases, including cancers and cardio-metabolic diseases. As heme iron intestinal absorption is finely regulated, we hypothesized that heme iron may act indirectly, through the peroxidation of dietary lipids, in food or in the intestinal lumen during digestion. This heme-iron-induced lipid peroxidation provokes the generation of toxic lipid oxidation products that could be absorbed, such as 4-hydroxynonenal (HNE). In a first experiment, heme iron given to rats by oral gavage together with the linoleic-acid-rich safflower oil induced the formation of HNE in the intestinal lumen. The HNE major urinary metabolite was elevated in the urine of the treated rats, indicating that this compound has been absorbed. In a second experiment, we showed that stable isotope-labeled HNE given orally to rats was able to reach non-intestinal tissues as a bioactive form and to make protein-adducts in heart, liver and skeletal muscle tissues. The presence of HNE-protein adducts in those tissues suggests a putative biological role of diet-originating HNE in extra-intestinal organs. This finding could have major consequences on the onset/development of chronic diseases associated with red meat over-consumption, and more largely to peroxidation-prone food consumption.
- 17 December 2020
- Published by MDPI AG in Antioxidants
- Vol. 9 (12) , 1293
Open AccessHeme-Iron-Induced Production of 4-Hydroxynonenal in Intestinal Lumen May Have Extra-Intestinal Consequences through Protein-Adduct Formation
Some epidemiological studies show that heme iron consumption, in red meat, is associated to the development of several chronic diseases, including cancers and cardio-metabolic diseases. As heme iron intestinal absorption is finely regulated, we hypothesized that heme iron may act indirectly, through the peroxidation of dietary lipids, in food or in the intestinal lumen during digestion. This heme-iron-induced lipid peroxidation provokes the generation of toxic lipid oxidation products that could be absorbed, such as 4-hydroxynonenal (HNE). In a first experiment, heme iron given to rats by oral gavage together with the linoleic-acid-rich safflower oil induced the formation of HNE in the intestinal lumen. The HNE major urinary metabolite was elevated in the urine of the treated rats, indicating that this compound has been absorbed. In a second experiment, we showed that stable isotope-labeled HNE given orally to rats was able to reach non-intestinal tissues as a bioactive form and to make protein-adducts in heart, liver and skeletal muscle tissues. The presence of HNE-protein adducts in those tissues suggests a putative biological role of diet-originating HNE in extra-intestinal organs. This finding could have major consequences on the onset/development of chronic diseases associated with red meat over-consumption, and more largely to peroxidation-prone food consumption.
- 1 December 2020
- Published by JLE in Gériatrie et Psychologie Neuropsychiatrie du Viellissement
- Vol. 18 (4) , 419-428
Cognitive aspects of attention deficits in Alzheimer's disease
Attention deficits are encountered very early in the development of Alzheimer's disease. While these deficits may be detected using classic clinical tests or even from simple observation, experimental tools enable a more precise evaluation of these deficits, typically by subtracting between conditions which vary the quantity of necessary attention, and by recording response times which allow a more precise and modulated measurement. The sensitivity of these tools can be further increased by analyzing the intra-individual variability of performance in these experiments, this variability being particularly important during the earliest stages of the disease. We present the cognitive aspects of these deficits by regrouping them according to the type of experiment used to highlight each deficit. Thus, we distinguish deficits of spatial attention orientation, of executive control and of sustained attention. In each section we present several of the more often employed experiments (spatial cueing, spatial search, dual-tasks, conflict tasks, vigilance tests), and draw a parallel between these experiments and everyday life.
- 1 December 2020
- Published by JLE in Gériatrie et Psychologie Neuropsychiatrie du Viellissement
- Vol. 18 (4) , 419-428
Cognitive aspects of attention deficits in Alzheimer's disease
Attention deficits are encountered very early in the development of Alzheimer's disease. While these deficits may be detected using classic clinical tests or even from simple observation, experimental tools enable a more precise evaluation of these deficits, typically by subtracting between conditions which vary the quantity of necessary attention, and by recording response times which allow a more precise and modulated measurement. The sensitivity of these tools can be further increased by analyzing the intra-individual variability of performance in these experiments, this variability being particularly important during the earliest stages of the disease. We present the cognitive aspects of these deficits by regrouping them according to the type of experiment used to highlight each deficit. Thus, we distinguish deficits of spatial attention orientation, of executive control and of sustained attention. In each section we present several of the more often employed experiments (spatial cueing, spatial search, dual-tasks, conflict tasks, vigilance tests), and draw a parallel between these experiments and everyday life.